Crohn's disease belongs to a group of conditions known as inflammatory bowel diseases (IBD). This chronic condition causes ...
Patients with moderate to severe Crohn’s disease who did not achieve clinical response to IV induction with Skyrizi benefitted from an additional 12 weeks of treatment, according to study results in ...
Ulcerative colitis (UC) is a chronic inflammatory disease of the gastrointestinal tract, characterized by inflammation and ...
The Canadian Press on MSN1d
AI can predict premature death among people with inflammatory bowel disease: studyA new study suggests AI can predict premature death among people who have inflammatory bowel disease, also known as Crohn's ...
The Food and Drug Administration (FDA) has approved Tremfya ® (guselkumab) for the treatment of adults with moderately to severely active Crohn disease (CD).
Nov. 17, 2023 — New AGA guideline outlines reliable blood and stool tests to monitor inflammation ... up to eight years before a diagnosis of Crohn's disease and up to three years before a ...
A gastrointestinal doctor reveals the mistakes you should avoid if you want to lower your risk of colon cancer.
More than 150,000 Americans could get diagnosed with colorectal cancer this year, but lifestyle changes can lower your risk, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback